Related Experiment Video
Updated: Jun 18, 2026

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Coronary bifurcation lesions: a current update
Samin K Sharma1, Joseph Sweeny, Annapoorna S Kini
1Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Hospital, Box 1030, One Gustave L. Levy Place, New York, NY 10029-6754, USA. samin.sharma@mountsinai.org
Insights
Coronary bifurcation lesions are complex to treat, leading to poorer outcomes. New drug-eluting stents and ongoing trials aim to improve treatment success for these challenging coronary artery sites.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- Coronary bifurcations are susceptible to atherosclerotic plaque buildup due to altered hemodynamics like turbulent blood flow and high shear stress.
- Interventions at coronary bifurcations historically show lower success rates, increased costs, longer hospital stays, and higher rates of restenosis compared to non-bifurcation sites.
Purpose of the Study:
- To review the challenges and current strategies for treating coronary bifurcation lesions.
- To highlight the role of novel devices and clinical trials in advancing bifurcation intervention outcomes.
Main Methods:
- Literature review of coronary bifurcation lesion characteristics and intervention outcomes.
- Discussion of treatment algorithms and emerging technologies.
- Analysis of ongoing randomized clinical trials.
Main Results:
- Coronary bifurcation interventions present unique challenges impacting procedural success and long-term outcomes.
- A simplified algorithm based on side branch characteristics can aid treatment decisions.
- Novel drug-eluting stents specifically designed for bifurcations are under investigation.
Conclusions:
- Treating coronary bifurcation lesions remains complex but is evolving with new devices and evidence.
- Ongoing research and clinical trials are crucial for improving patient outcomes in bifurcation interventions.
Abstract:
Coronary bifurcations are prone to develop atherosclerotic plaque because of turbulent blood flow and high shear stress. When compared with nonbifurcation coronary interventions, bifurcation interventions have historically reported a lower rate of procedural success, higher procedural costs, longer hospitalization, and higher clinical and angiographic restenosis. Treating bifurcation lesions is challenging, but a simple algorithm based on the side branch size, stenosis, and angulation can be used. The ongoing development of novel drug-eluting stent devices designed specifically for coronary bifurcations and the large randomized clinical trials being conducted to address their utility will add to the already present literature regarding treatment of coronary bifurcation lesions.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
